Sam Eiber Analyst PerformanceVice President, Equity Research at BTIG ResearchSam Eiber is a stock analyst at BTIG Research in the medical sector, covering 6 publicly traded companies. Over the past year, Sam Eiber has issued 14 stock ratings, including and buy recommendations. While full access to Sam Eiber's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sam Eiber's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings16 Last 1 YearsBuy Recommendations93.75% 15 Buy RatingsCompanies Covered6 Unique Companies Ratings Distribution16RatingsDistribution of strong buy, buy, hold, and sell ratings by Sam Eiber.RatingPercentageCount Strong Buy0.0%0 ratings Buy93.8%15 ratings Hold6.3%1 ratings Sell0.0%0 ratingsOut of 16 total stock ratings issued by Sam Eiber at BTIG Research, the majority (93.8%) have been Buy recommendations, followed by 6.3% Hold.Best & Worst CallsBest Call000.0%EOLSApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ6 companiesSam Eiber, an analyst at BTIG Research, currently covers 6 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical6 companies100.0%Sam Eiber of BTIG Research specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED PRODUCTS3 companies50.0%MEDICAL SERVICES2 companies33.3%MED/DENTAL - SUPP1 company16.7% About Sam EiberSam Eiber is a Vice President and Medical Technology Analyst at BTIG. Prior to his current role, he was a Senior Associate at BTIG, covering the medical technology sector with an emphasis on cardiovascular, diabetes and aesthetics companies. Mr. Eiber earned his bachelor’s degree in finance from the Questrom School of Business at Boston University.Follow on LinkedIn Sam Eiber's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsESTAEstablishment Labs5/7/2026Boost Price Target$74.63$90.00Buy$0.0000.00% ROIESTAEstablishment Labs4/29/2026Reiterated Rating$64.40$88.00Buy$0.0000.00% ROIAPYXApyx Medical3/11/2026Upgrade$3.45$6.00Buy$0.0000.00% ROISBCSBC Medical Group3/6/2026Initiated Coverage$3.66$8.00Buy$0.0000.00% ROIEOLSEvolus3/4/2026Reiterated Rating$4.13$13.00Buy$0.0000.00% ROIESTAEstablishment Labs2/24/2026Boost Price Target$79.67$88.00Buy$0.0000.00% ROIMMSIMerit Medical Systems2/6/2026Initiated Coverage$79.63$107.00Buy$0.0000.00% ROIMMSIMerit Medical Systems2/6/2026Initiated Coverage$82.50$107.00Buy$0.0000.00% ROIEOLSEvolus1/22/2026Lower Price Target$4.90$13.00Buy$0.0000.00% ROIESTAEstablishment Labs12/31/2025Boost Price Target$72.92$86.00Buy$0.0000.00% ROIESTAEstablishment Labs11/14/2025Boost Price Target$64.75$81.00Buy$0.0000.00% ROIESTAEstablishment Labs11/5/2025Boost Price Target$60.87$70.00Buy$0.0000.00% ROIEOLSEvolus9/8/2025Reiterated Rating$7.67$18.00Buy$0.0000.00% ROIEOLSEvolus8/6/2025Lower Price Target$6.15$18.00Buy$0.0000.00% ROIINMDInMode4/29/2025Downgrade$14.26Neutral$00.0000.00% ROIEOLSEvolus4/17/2025Initiated Coverage$10.11$21.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupMorgan StanleyRoyal Bank Of CanadaJefferies Financial GroupThe Goldman Sachs GroupStifel NicolausRaymond James FinancialMizuhoBank of AmericaKeyCorpSanford C. BernsteinWolfe ResearchCICC Research Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
